查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1552613

癌症医学基因组学市场规模、份额和趋势分析报告：按产品、按应用、按技术、按地区和细分市场预测，2024-2030

Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Product (Instruments), By Application (Diagnostics, Personalized Medicine), By Technology (Genome Sequencing, PCR), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格
简介目录

基因组学市场成长与癌症医学趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球癌症治疗基因组学市场预计将达到 509.7 亿美元。

预计2024年至2030年复合年增长率将达16.0%。癌症盛行率的不断上升，加上次世代定序在诊断和治疗中的应用，预计将为市场带来未来的成长机会。癌症发生率的增加将在未来几年引发对具有成本效益和准确诊断的需求。

此外，对癌症分子表征以确定治疗标靶的个人化医疗的需求不断增长，正在推动市场成长。同样，基因组定序成本降低、医疗保健支出增加以及有效癌症诊断和治疗方法的发展等因素也促进了基因组学在癌症护理中的潜在增长。

癌症医学市场中的基因组学报告亮点

  • 就截至 2023 年的销售份额而言，由于设备相关高成本，设备细分市场将占整个市场的 54.8%。同时，耗材是基因组检测中使用最广泛的产品类别。
  • 由于基因组分析的外包活动增加，预计在预测期内，对次世代定序、PCR 以及其他癌症风险管理和基因检测等服务的需求将会成长。进行基因测试的高昂成本以及人们对使用这些技术的相关好处的认识不断增强，是对该细分市场产生重大影响的驱动因素。
  • 由于对有效治疗癌症的需求不断增加以及製造商对新产品开发的生物製药投资增加，预计药物发现和开发领域在预测期内将呈现 18.5% 的有利复合年增长率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章癌症医学基因组学市场的变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 癌症护理中的基因组市场分析工具
    • 波特的分析
    • PESTEL分析

第四章癌症医学基因组学市场：按产品估计和趋势分析

  • 细分仪表板
  • 癌症医学基因组学市场：2023 年和 2030 年按产品分類的变异分析
  • 装置
  • 消耗品
  • 服务

第五章癌症医学中的基因组学市场：应用估计和趋势分析

  • 细分仪表板
  • 癌症医学基因组学市场：2023 年和 2030 年应用变化分析
  • 诊断
  • 个人化医疗
  • 药物发现与开发
  • 调查

第六章癌症医学基因组学市场：技术估计和趋势分析

  • 细分仪表板
  • 癌症护理基因组学市场：2023 年和 2030 年技术变异分析
  • 基因组序列分析
  • PCR
  • 微阵列
  • 核酸萃取精製
  • 其他的

第七章癌症医学基因组学市场：区域估计和趋势分析

  • 2023 年和 2030 年癌症医学基因组学市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Agilent Technologies, Inc.,
    • F. Hoffmann-La Roche Ltd
    • Beckman Coulter, Inc.,
    • Illumina Inc.
    • Abbott
    • Cancer Genetics Inc.
    • Bio-Rad Laboratories
    • PacBio
    • GE Healthcare
    • Quest Diagnostics Incorporated
    • PerkinElmer
    • Luminex
简介目录
Product Code: 978-1-68038-717-9

Genomics In Cancer Care Market Growth & Trends:

The global genomics in cancer care market size is expected to reach USD 50.97 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 16.0% from 2024 to 2030. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.

Genomics In Cancer Care Market Report Highlights:

  • Instrument segment dominated the overall market in terms of revenue share as of 2023 and accounted for 54.8% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
  • Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
  • Drug discovery and development segment is expected to show lucrative CAGR of 18.5% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Genomic in Cancer Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Genomic in Cancer Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Genomics in Cancer Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Genomics in Cancer Care Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Genomics in Cancer Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Genomics in Cancer Care Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Personalized Medicine
    • 5.4.1. Personalized Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Discovery & Development
    • 5.5.1. Drug Discovery & Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Research
    • 5.6.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Genomics in Cancer Care Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Genomics in Cancer Care Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Genome Sequencing
    • 6.3.1. Genome Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. PCR
    • 6.4.1. PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Microarrays
    • 6.5.1. Microarrays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Nucleic Acid Extraction & Purification
    • 6.6.1. Nucleic Acid Extraction & Purification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Other
    • 6.7.1. Other Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Genomics in Cancer Care Market: Regional Estimates & Trend Analysis

  • 7.1. Genomics in Cancer Care Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Genomics in Cancer Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Agilent Technologies, Inc.,
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc.,
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Illumina Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Abbott
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Cancer Genetics Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Bio-Rad Laboratories
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. PacBio
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. GE Healthcare
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Quest Diagnostics Incorporated
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. PerkinElmer
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. Luminex
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives